Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha.
Phosphoinositide 3-kinases produce 3'-phosphorylated phosphoinositides that act as second messengers to recruit other signalling proteins to the membrane. Pi3ks are activated by many extracellular stimuli and have been implicated in a variety of cellular responses. The Pi3k gene family is complex and the physiological roles of different classes and isoforms are not clear. The gene Pik3r1 encodes three proteins (p85 alpha, p55 alpha and p50 alpha) that serve as regulatory subunits of class IA Pi3ks (ref. 2). Mice lacking only the p85 alpha isoform are viable but display hypoglycaemia and increased insulin sensitivity correlating with upregulation of the p55 alpha and p50 alpha variants. Here we report that loss of all protein products of Pik3r1 results in perinatal lethality. We observed, among other abnormalities, extensive hepatocyte necrosis and chylous ascites. We also noted enlarged skeletal muscle fibres, brown fat necrosis and calcification of cardiac tissue. In liver and muscle, loss of the major regulatory isoform caused a great decrease in expression and activity of class IA Pi3k catalytic subunits; nevertheless, homozygous mice still displayed hypoglycaemia, lower insulin levels and increased glucose tolerance. Our findings reveal that p55 alpha and/or p50 alpha are required for survival, but not for development of hypoglycaemia, in mice lacking p85 alpha.
Fruman
D A
DA
Division of Signal Transduction, Beth Israel Deaconess Medical Center Boston, Massachusetts, USA.
Mauvais-Jarvis
F
F
Pollard
D A
DA
Yballe
C M
CM
Brazil
D
D
Bronson
R T
RT
Kahn
C R
CR
Cantley
L C
LC
D000015:Abnormalities, Multiple / Q000235:genetics*; D002001:Adipose Tissue, Brown / Q000473:pathology; D000818:Animals; D021461:Animals, Outbred Strains; D002114:Calcinosis / Q000235:genetics; D009202:Cardiomyopathies / Q000235:genetics; D002384:Catalysis; D002915:Chylous Ascites / Q000235:genetics*; D003433:Crosses, Genetic; D019281:Dimerization; D004790:Enzyme Induction; D005260:Female; D005796:Genes; D005804:Genes, Lethal; D005838:Genotype; D005856:Germ-Free Life; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology; D006984:Hypertrophy; D007003:Hypoglycemia / Q000235:genetics*; D007328:Insulin / Q000494:pharmacology; D008099:Liver / Q000473:pathology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008813:Mice, Inbred ICR; D018345:Mice, Knockout; D018485:Muscle Fibers, Skeletal / Q000473:pathology; D009336:Necrosis; D019869:Phosphatidylinositol 3-Kinases / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D010766:Phosphorylation; D020033:Protein Isoforms / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D011499:Protein Processing, Post-Translational / Q000235:genetics; D021122:Protein Subunits; D015290:Second Messenger Systems / Q000235:genetics
D007328:Insulin; D020033:Protein Isoforms; D021122:Protein Subunits; D019869:Phosphatidylinositol 3-Kinases; D005947:Glucose